Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis

Aún no traducido Aún no traducido
Autores
Categoría Estudio primario
Registro de estudiosclinicaltrials.gov
Año 2008
This is a Phase IIIb multicenter study to evaluate the safety and efficacy of certolizumab pegol (CZP) administered to patients with moderate-to-severe rheumatoid arthritis.
Epistemonikos ID: 08dd15f43d69665308176b2966ebe9b3cc85b51b
First added on: Mar 22, 2022